AUM$2.29B
Expense Ratio0.54%
NAV$199.74
Holdings30
InceptionJun 19, 2006
Price Chart
Key Statistics
Previous Close
$199.26Day Range
$193.53$196.81
52-Week Range
$145.67$221.86
Avg Volume
171.0KDividend Yield
0.58%Expense Ratio
0.54%AUM
$2.29BShares Outstanding
6.2MSector Breakdown
| Sector | Weight % |
|---|---|
| Healthcare | 100.00% |
Country Allocation
| Country | Weight % |
|---|---|
| United States | 83.68% |
| Germany | 3.61% |
| Ireland | 3.39% |
| Netherlands | 3.32% |
| Switzerland | 3.16% |
| Denmark | 2.81% |
| Other | 0.03% |
Fund Information
- Issuer
- First Trust
- Category
- Healthcare
- Subcategory
- Biotech
- Inception Date
- Jun 19, 2006
- Exchange
- NYSE_ARCA
- Description
- The First Trust NYSE Arca Biotechnology Index Fund is an exchange-traded index fund. The investment objective of the Fund is to replicate as closely as possible, before fees and expenses, the price and yield of the NYSE Arca Biotechnology Index.
Similar ETFs
The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund issued by First Trust that launched on Jun 19, 2006. It currently manages $2.29B in assets under management. The fund charges an expense ratio of 0.54%. The fund holds 30 securities in its portfolio. It falls under the Healthcare category.
Top 10 holdings represent 39.9% of the fund
| Rank | Symbol | Name | Weight % | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | MRNA | Moderna, Inc. | 5.73% | 2,382,500 | $131.0M |
| 2 | GILD | Gilead Sciences, Inc. | 4.38% | 674,832 | $100.3M |
| 3 | AMGN | Amgen Inc. | 4.11% | 250,565 | $94.1M |
| 4 | UTHR | United Therapeutics Corporation | 3.96% | 169,063 | $90.6M |
| 5 | VRTX | Vertex Pharmaceuticals Incorporated | 3.84% | 176,141 | $87.9M |
| 6 | BMRN | BioMarin Pharmaceutical Inc. | 3.69% | 1,386,199 | $84.4M |
| 7 | EXAS | Exact Sciences Corporation | 3.62% | 800,328 | $82.7M |
| 8 | BIIB | Biogen Inc. | 3.59% | 435,558 | $82.1M |
| 9 | KRYS | Krystal Biotech, Inc. | 3.57% | 312,599 | $81.6M |
| 10 | REGN | Regeneron Pharmaceuticals, Inc. | 3.46% | 102,592 | $79.2M |
| 11 | NBIX | Neurocrine Biosciences, Inc. | 3.42% | 601,809 | $78.2M |
| 12 | ARGX | argenx SE (ADR) | 3.37% | 103,683 | $77.0M |
| 13 | EXEL | Exelixis, Inc. | 3.35% | 1,855,578 | $76.6M |
| 14 | HALO | Halozyme Therapeutics, Inc. | 3.34% | 1,127,615 | $76.5M |
| 15 | ALKS | Alkermes Plc | 3.34% | 2,755,157 | $76.4M |
Detailed Returns
| Period | Return | ETF | Cat. Avg | vs Avg |
|---|---|---|---|---|
| 1D | -2.32% | — | ||
| 1W | -2.63% | — | ||
| 1M | -5.23% | — | ||
| 3M | -4.63% | — | ||
| 6M | +13.56% | — | ||
| YTD | -4.08% | — | ||
| 1Y | +18.44% | — | ||
| 3Y | +30.86% | — | ||
| 5Y | +20.41% | — |
Moving Averages
20-Day MA
$205.80
Below 20-Day MA50-Day MA
$210.73
Below 50-Day MA200-Day MA
$187.29
Above 200-Day MAPrice with Moving Averages
Support & Resistance
52-Week High
$221.86
Current Price
$194.63
52-Week Low
$145.67
$145.67$221.86
Current Yield
0.58%
Annual Dividend
$1.3048
Frequency
4x/year
Last Ex-Date
Dec 13, 2024
Dividend History
| Ex-Date | Amount | Pay Date |
|---|---|---|
| Dec 13, 2024 | $1.1726 | Dec 31, 2024 |
| Sep 23, 2015 | $0.0197 | Sep 30, 2015 |
| Jun 24, 2015 | $0.0649 | Jun 30, 2015 |
| Mar 25, 2015 | $0.0476 | Mar 31, 2015 |
| Dec 23, 2014 | $0.0524 | Dec 31, 2014 |
| Jun 23, 2008 | $0.2697 | Jun 30, 2008 |
Dividend Payments Over Time
Category Comparison
| Metric | FBT | Healthcare(223 ETFs) | Biotech(39 ETFs) |
|---|---|---|---|
| Fund Info | |||
| Expense Ratio | 0.54% | 0.60% | 0.84% |
| AUM | $2.29B | $1.25B | $1.62B |
| Dividend Yield | 0.58% | 2.75% | 14.38% |
| Avg Volume | 171.0K | 769.9K | 1.3M |
| Holdings | 30 | 182 | 67 |
| Performance | |||
| 1-Month Return | -6.00% | -3.02% | -2.05% |
| 6-Month Return | +12.08% | +5.85% | +15.05% |
| YTD Return | -3.52% | +0.17% | +1.05% |
| 1-Year Return | +16.19% | +16.65% | +24.43% |
Compare with Another ETF
Search for an ETF to compare with FBT: